Last reviewed · How we verify

standard prednisolone treatment — Competitive Intelligence Brief

standard prednisolone treatment (standard prednisolone treatment) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Corticosteroid (glucocorticoid). Area: Immunology / Rheumatology / Pediatrics.

marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor (GR) Immunology / Rheumatology / Pediatrics Small molecule Live · refreshed every 30 min

Target snapshot

standard prednisolone treatment (standard prednisolone treatment) — Institute of Child Health. Prednisolone is a corticosteroid that suppresses the immune system and reduces inflammation by binding to glucocorticoid receptors and inhibiting pro-inflammatory cytokine production.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
standard prednisolone treatment TARGET standard prednisolone treatment Institute of Child Health marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor (GR)
Prednisolone, prednisone, or methylprednisolone Prednisolone, prednisone, or methylprednisolone Children's Hospital of Philadelphia marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor (GR)
Oral prednisolone Taper Oral prednisolone Taper Berinstein, Jeffrey marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor (GR)
Kenalog (triamcinolone) Kenalog (triamcinolone) Walter Reed National Military Medical Center marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor
Prednisone/Prednisolone/Methylprednisolone Prednisone/Prednisolone/Methylprednisolone Hoffmann-La Roche marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor (GR)
Kenalog 10 Kenalog 10 The University of Western Australia marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor
Solu-medrol or placebo administration Solu-medrol or placebo administration Erasme University Hospital marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor (GR)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Corticosteroid (glucocorticoid) class)

  1. Assistance Publique - Hôpitaux de Paris · 3 drugs in this class
  2. Astellas Pharma Inc · 2 drugs in this class
  3. Sanofi · 2 drugs in this class
  4. Xinqiao Hospital of Chongqing · 2 drugs in this class
  5. Berinstein, Jeffrey · 2 drugs in this class
  6. Ain Shams University · 2 drugs in this class
  7. Children's Hospital of Philadelphia · 1 drug in this class
  8. Celgene · 1 drug in this class
  9. Hamilton Health Sciences Corporation · 1 drug in this class
  10. Erasme University Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). standard prednisolone treatment — Competitive Intelligence Brief. https://druglandscape.com/ci/standard-prednisolone-treatment. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: